Twist Bioscience TWST
$103.32 −$8.30 (-7.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $105.01 +1.64%
Open$108.39
Prev close$111.62
Day range$101.00 – $108.50
Volume3.38M
Market cap$6.85B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q4, ended Sep 2026
Revenue$126.64M+27.9% YoY
Operating profit-$24.41M+18.4% YoY
Net profit-$20.62M+24.0% YoY
Diluted EPS-$0.32+28.9% YoY
Free cash flow-$26.98M-11.3% YoY
Operating cash flow-$173,000.00
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin52.4%
Operating margin-28.8%
Net margin-28.3%
Return on equity-19.1%
Return on assets-14.8%
Return on invested capital-17.7%
Current ratio5.86
Liabilities / assets20.8%
Cash & investments$581.91M
Total debt$86.54M
Net cash (debt)$495.37M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $459.43M | $126.64M | $118.38M | $110.72M | $103.70M |
| Total Operating Revenue | $459.43M | $126.64M | $118.38M | $110.72M | $103.70M |
| Cost of Revenue | $218.63M | $59.39M | $55.92M | $53.59M | $49.73M |
| Gross Profit | $240.80M | $67.25M | $62.45M | $57.12M | $53.97M |
| Operating Expense | $373.05M | $91.67M | $98.73M | $95.78M | $87.07M |
| Selling and Admin Expenses | $301.22M | $74.68M | $80.71M | $76.09M | $69.94M |
| Research & Development | $71.84M | $16.99M | $18.03M | $19.70M | $17.13M |
| Operating Profit | -$132.25M | -$24.41M | -$36.28M | -$38.66M | -$33.10M |
| Net Non-Operating Interest Income (Expense) | $8.80M | $3.42M | $1.50M | $1.71M | $2.18M |
| Non-Operating Interest Income | $8.80M | $3.42M | $1.50M | $1.71M | $2.18M |
| Other Income (Expense) | -$6.35M | $170,000.00 | $40,000.00 | -$7.03M | $671,000.00 |
| Special Income (Charges) | -$7.21M | $0.00 | $0.00 | -$7.21M | – |
| -Less:Impairment of Capital Assets | $0.00 | – | – | – | – |
| -Less:Other Special Charges | $7.21M | $0.00 | – | $7.21M | – |
| -Gain on Sale Of Business | $0.00 | $0.00 | $0.00 | – | – |
| Other Non-Operating Income (Expenses) | $856,000.00 | $170,000.00 | $40,000.00 | $175,000.00 | $671,000.00 |
| Pretax Profit | -$129.80M | -$20.82M | -$34.74M | -$43.98M | -$30.25M |
| Tax | $406,000.00 | -$201,000.00 | $311,000.00 | $43,000.00 | $253,000.00 |
| Net Profit | -$130.20M | -$20.62M | -$35.05M | -$44.02M | -$30.51M |
| Profit from Continuing Operations | -$130.20M | -$20.62M | -$35.05M | -$44.02M | -$30.51M |
| Net Income to Parent Company | -$130.20M | -$20.62M | -$35.05M | -$44.02M | -$30.51M |
| Net Income to Common Stockholders | -$130.20M | -$20.62M | -$35.05M | -$44.02M | -$30.51M |
| Basic EPS | -$2.08 | -$0.32 | -$0.56 | -$0.71 | -$0.50 |
| Diluted EPS | -$2.08 | -$0.32 | -$0.56 | -$0.71 | -$0.50 |
Balance sheet
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Assets | $1.12B | $1.12B | $672.44M | $676.21M | $638.09M |
| Total Current Assets | $737.22M | $737.22M | $321.30M | $323.44M | $303.88M |
| Cash and Cash Equivalents & Short-Term Investments | $581.91M | $581.91M | $166.84M | $171.67M | $197.95M |
| -Cash and Cash Equivalents | $533.99M | $533.99M | $117.44M | $122.67M | $148.59M |
| -Short Term Investments | $47.92M | $47.92M | $49.40M | $49.00M | $49.36M |
| Receivables | $93.42M | $93.42M | $87.58M | $87.45M | $50.06M |
| -Accounts Receivable | $70.19M | $70.19M | $65.06M | $64.15M | $50.06M |
| -Other Receivables | $23.22M | $23.22M | $22.53M | $23.30M | – |
| Prepaid Assets | $11.38M | $11.38M | $9.96M | $9.34M | – |
| Inventory | $46.41M | $46.41M | $35.16M | $33.52M | $32.92M |
| Restricted Cash | $1.65M | $1.65M | – | – | – |
| Other Current Assets | $2.46M | $2.46M | $21.75M | $21.47M | $22.95M |
| Total Non-Current Assets | $384.58M | $384.58M | $351.14M | $352.78M | $334.20M |
| Net PPE | $191.60M | $191.60M | $180.62M | $181.88M | $177.39M |
| -Gross PPE | $309.95M | $309.95M | $292.33M | $287.79M | $277.55M |
| -Accumulated Depreciation | -$118.35M | -$118.35M | -$111.71M | -$105.91M | -$100.17M |
| Investments and Advances | $68.09M | $68.09M | $68.09M | $68.09M | $54.34M |
| -Available for Sale Securities | $68.09M | $68.09M | $68.09M | $68.09M | $54.34M |
| Goodwill and Other Intangible Assets | $116.36M | $116.36M | $94.93M | $95.19M | $95.36M |
| -Goodwill | $82.20M | $82.20M | $82.20M | $82.20M | $82.20M |
| -Other Intangible Assets | $34.16M | $34.16M | $12.73M | $13.00M | $13.16M |
| Other Non-Current Assets | $8.54M | $8.54M | $7.51M | $7.62M | $7.12M |
| Total Liabilities | $233.79M | $233.79M | $226.70M | $221.12M | $181.99M |
| Total Current Liabilities | $125.81M | $125.81M | $120.26M | $119.98M | $80.44M |
| Payables | $33.06M | $33.06M | $24.42M | $19.66M | $16.39M |
| -Accounts Payable | $24.85M | $24.85M | $17.04M | $14.68M | $12.49M |
| -Total Tax Payable | $8.21M | $8.21M | $7.38M | $4.98M | $3.90M |
| Current Accrued Expenses | $38.91M | $38.91M | $40.18M | $45.51M | $23.41M |
| Short-Term Debt and Capital Lease Obligation | $8.45M | $8.45M | $8.63M | $10.44M | $12.24M |
| -Current Capital Lease Obligation | $8.45M | $8.45M | $8.63M | $10.44M | $12.24M |
| Current Deferred Liabilities | $7.02M | $7.02M | $6.47M | $7.10M | $9.02M |
| Other Current Liabilities | $49,000.00 | $49,000.00 | $5.68M | $10.26M | $548,000.00 |
| Total Non-Current Liabilities | $107.98M | $107.98M | $106.44M | $101.14M | $101.55M |
| Long Term Debt and Capital Lease Obligation | $86.54M | $86.54M | $84.96M | $85.40M | $85.81M |
| -Long Term Capital Lease Obligation | $86.54M | $86.54M | $84.96M | $85.40M | $85.81M |
| Non-Current Deferred Liabilities | $15.00M | $15.00M | $15.00M | $15.00M | $15.00M |
| Other Non-Current Liabilities | $6.45M | $6.45M | $6.48M | $746,000.00 | $741,000.00 |
| Total Equity | $888.02M | $888.02M | $445.74M | $455.09M | $456.10M |
| Stockholders' Equity | $888.02M | $888.02M | $445.74M | $455.09M | $456.10M |
| Capital Stock | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $0.00 |
| -Common Stock | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $0.00 |
| Additional Paid-In Capital | $2.34B | $2.34B | $1.88B | $1.85B | $1.81B |
| Retained Earnings | -$1.45B | -$1.45B | -$1.43B | -$1.39B | -$1.35B |
| Gains/Losses Not Affecting Retained Earnings | -$680,000.00 | -$680,000.00 | -$655,000.00 | -$639,000.00 | -$571,000.00 |
Cash flow
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$41.43M | -$173,000.00 | $1.12M | -$17.56M | -$24.81M |
| Net cash flow from continuing operations | -$41.43M | -$173,000.00 | $1.12M | -$17.56M | -$24.81M |
| Net Income from Continuing Operations | -$130.20M | -$20.62M | -$35.05M | -$44.02M | -$30.51M |
| Depreciation & Depletion & Amortization | $26.48M | $7.10M | $6.78M | $6.41M | $6.19M |
| Other Non-Cash Items | $265,000.00 | $938,000.00 | $161,000.00 | -$498,000.00 | -$336,000.00 |
| Change in Working Capital | -$7.83M | -$7.06M | $11.05M | $1.61M | -$13.44M |
| -Change in Receivables | -$13.80M | -$5.30M | -$1.09M | -$14.24M | $6.83M |
| -Change in Inventory | -$18.10M | -$11.25M | -$1.65M | -$590,000.00 | -$4.62M |
| -Change in Prepaid Assets | -$21.78M | -$2.82M | -$99,000.00 | -$11.13M | -$7.74M |
| -Change in Payables and Accrued Expense | $47.29M | $13.45M | $13.77M | $29.52M | -$9.46M |
| -Change in Other Current Assets | -$1.44M | -$1.13M | $114,000.00 | -$641,000.00 | $225,000.00 |
| Net cash flow from investing | -$53.09M | -$20.25M | -$10.20M | -$12.71M | -$9.93M |
| Net Cash Flow from Continuing Investing Activities | -$53.09M | -$20.25M | -$10.20M | -$12.71M | -$9.93M |
| Net PPE Purchase and Sale | -$47.58M | -$19.96M | -$9.76M | -$7.89M | -$9.97M |
| Net Intangibles Purchase and Sale | -$6.95M | -$6.85M | $0.00 | – | – |
| Net Business Purchase and Sale | $0.00 | $5.00M | $0.00 | – | – |
| Net Investment Purchase and Sale | $1.45M | $1.56M | -$435,000.00 | $281,000.00 | $41,000.00 |
| Financing Cash Flow | $446.68M | $438.46M | $3.79M | $4.14M | $298,000.00 |
| Net Cash Flow from Continuing Financing Activities | $446.68M | $438.46M | $3.79M | $4.14M | $298,000.00 |
| Net Common Stock Issuance | $424.79M | $424.80M | -$6,000.00 | -$8,000.00 | -$2,000.00 |
| Proceeds from Stock Option Exercised | $21.89M | $13.65M | $3.79M | $4.15M | $300,000.00 |
| Ending Cash Balance | $537.61M | $537.61M | $119.57M | $124.85M | $150.99M |
| Net Change in Cash | $352.16M | $418.03M | -$5.30M | -$26.13M | -$34.45M |
| Beginning Cash Balance | $185.43M | $119.57M | $124.85M | $150.99M | $185.43M |
| Effect of Exchange Rate Changes | $24,000.00 | $11,000.00 | $10,000.00 | -$6,000.00 | $9,000.00 |
| Free Cash Flow | -$95.96M | -$26.98M | -$8.65M | -$25.55M | -$34.79M |
| -Change in Other Current Liabilities | – | – | – | – | $1.32M |
No comments yet — be the first to weigh in on TWST.
Sign in to join the discussion.